ARES
NYSE · Financial Services
Ares Management Corp - A
$120.78
-5.12 (-4.07%)
ARES News30 articles
Blue Owl Capital Shares Surge as Private Credit Worries Ease
Blue Owl shares surged 5.5% to $10.225 as private-credit asset managers rebounded after Blackstone's withdrawal cap eased redemption fears. The sector remains under watch.
Broadcom Plunge 13% After Hours Sparks Tech Selloff, Dow Drops 621 Points
Broadcom slid 13.7% after hours after missing Q2 revenue estimates and keeping AI-chip sales forecast unchanged, triggering a broader market decline with the Dow falling 621 points.
Markets Mixed as Oil Surge, Slowing PMI Weigh on Sentiment
U.S. stocks were mixed Tuesday as a rebound in oil prices and signs of slowing economic growth tempered Monday's rally. The Dow Jones Industrial Average advanced, while the Nasdaq Composite slipped.
Blue Owl Shares Dip as BofA Calls Private Credit Fears Excessive
Blue Owl Capital shares declined slightly on Thursday following a Bank of America research note stating concerns around private credit managers are exaggerated. The stock has fallen nearly 40% year-to-date amid broader sector strain.
Blue Owl Shares Gain Amid Sector Rebound, But Private Credit Concerns Linger
Blue Owl Capital shares advanced 2.2% as alternative-asset managers rebounded, though ongoing worries about private credit valuations and fund liquidity kept sector sentiment cautious.
Goldman Offers Hedge Funds Swap to Short Software Loans as AI Risks Mount
Goldman Sachs is marketing a total return swap allowing hedge funds to bet against corporate loans in the software sector, fueled by concerns that artificial intelligence could disrupt credit markets. No trades have been executed yet.
KKR Shares Surge 4% Amid Governance Vote and Software Sector Scrutiny
KKR & Co. rebounded sharply Friday, gaining over 4% as investors weighed a major acquisition and upcoming governance changes against concerns over software exposure and loan leverage.
Ambu shares sink on Danske downgrade amid urology headwinds
Ambu shares fell 9.4% after Danske Bank downgraded the stock to sell, citing faster competition and price pressure in urology, weak ureteroscope traction, and a limited product portfolio.
AT&T Shares Surge on Cash Return Prospects Ahead of Q2 Report
AT&T shares climbed 3.21% to $22.81 on heavy volume, with its 2026 free-cash-flow target implying an 11% yield. Investors await Q2 results on July 22, where free cash flow guidance of $4.0-$4.5 billion will test the stock's cash-yield appeal.
Nokia Shares Surge on AI Network Automation Deals with Cloud Giants
Nokia shares surged up to 3.6% after unveiling AI-powered autonomous network releases with Google Cloud, AWS, and Databricks, driving automation above 90% and productivity gains of 60-80%.
Cerebras Shares Hover Near IPO Level After Margin Guidance Disappoints
Cerebras shares fell 14.8% premarket after guiding full-year core gross margin to 38-41%, far below Q1's 47%, as cloud revenue growth pressured profitability, leaving stock just 4.5% above IPO price.
Rheinmetall Shares Plunge 13.5% Amid Fears of Lost German Frigate Contract
Rheinmetall shares plunged 13.5% after reports that Germany might scrap a €12 billion frigate contract, erasing €7.4 billion in market value and fueling investor concerns about the company's naval ambitions.
American Airlines Shares Hinge on Fuel-Led Guidance Boost as Rivals Outperform
American Airlines stock trades near its average analyst target, with investors seeking stronger earnings guidance as lower jet fuel costs fail to lift shares as much as rivals.
Delta CEO: Lower Jet Fuel Alone Won't Cut Fares Without Capacity Growth
Delta CEO Ed Bastian says lower jet fuel prices alone won't lower fares without increased flight capacity. U.S. carriers paid $6.47 billion for fuel in April, up 78% from last year, while Q3 capacity growth is just 0.4%.
IREN Shares Slide Amid Analyst Divide on AI Cloud Revenue Prospects
IREN shares dropped 3.78% to $54.72 as tech stocks fell on AI spending worries. Analysts remain split on the stock's outlook, with targets from $36 to $100.
Blue Owl Shares Drop Near 52-Week Low Amid Credit Fund Filing and Redemption Concerns
Blue Owl Capital shares fell 3.4% to $8.91, nearing a 52-week low, as investors weigh a 10.3% dividend yield against $1.2 billion in redemptions and 13.9% software-credit exposure.
Joby Aviation Shares Slide on Heavy Trading, Short Interest Pressure
Joby Aviation dropped 3.14% on Tuesday with volume surging to 38.08 million shares, reflecting high short interest and no company news. The stock is 54% below its 52-week high.
Aurora Innovation Shares Fall Amid Cash Burn Concerns and Pilot Revenue
Aurora Innovation shares slid 2.1% to $6.42, landing between Uber's block sale price and a director's purchase level, as the autonomous truck developer reports $1 million in Q1 revenue and expects further capital raises.
Novo Nordisk B Shares Surge on South African Court Ruling Against Compounder
Novo Nordisk B shares surged 9.9% in three sessions after a South African court halted iDexis from supplying compounded semaglutide, potentially shifting demand to Novo.
Opendoor Shares Slip on Russell 3000 Inclusion and Dilution Fears
Opendoor shares dropped 1.9% as the company prepares for Russell 3000 index inclusion, with investors concerned about dilution from convertible notes and anti-dilutive securities.
BTQ Technologies Shares Jump 31% on Quantum Security Push and New Adviser
BTQ Technologies surged over 30% to $5.80 on Nasdaq after naming Brandt Pasco as U.S. strategic adviser, following White House orders to accelerate quantum computing and post-quantum cryptography adoption.
TSMC ADR Premium Shrinks, Sparking 6% Slide in US Shares
TSMC's US shares dropped 6% as the premium over Taipei shares shrank sharply, indicating a flow-driven adjustment rather than a change in earnings outlook.
Ambev Shares Rise on Payout, Rate Outlook, and World Cup Demand
Ambev shares rose 1.05% to 16.34 reais as a new payout and World Cup demand offset cautious rate signals. Q1 earnings showed 8.1% organic revenue growth.
Pfizer Shares Dip as Key Lung Cancer Drug Fails Trial, Pressuring Growth Plans
Pfizer shares slipped 0.8% after a key lung cancer drug from its Seagen acquisition missed survival goals in a late-stage trial, intensifying pressure on growth plans.
Plug Power Shares Stagnate as Liquidity Milestone Looms
Plug Power shares hover near $2.79 as the hydrogen firm races to close a critical asset sale by month-end to shore up liquidity, with the stock still down 39% from its peak.
Robinhood Shares Dip After $2 Billion Debt Issuance
Robinhood shares slipped 0.6% after pricing a $2 billion convertible note sale, raising $1.97 billion for buybacks, capped calls, and growth initiatives.
Atlantic International Shares Skyrocket on Dutch Deal, Filing Reveals Deepening Losses
Atlantic International stock soared 155% after its Circle8 unit won a $52M Dutch government contract, but the company's latest filing reveals widening losses, heavy debt, and substantial doubt about its ability to continue.
Rigetti Shares Dip After Quantum Policy Push Fails to Sustain Rally
Rigetti Computing shares erased early gains Tuesday, as White House quantum targets and a $100M incentive failed to offset a $26M quarterly loss.
Trump's 2028 Quantum Goal Lifts D-Wave Shares
D-Wave shares gained 3.1% to $25.23 after Trump's quantum executive orders, but Q1 revenue fell 81% to $2.9M, highlighting risk.
Oracle Shares Slide on AI Spending Fears, 21,000 Job Cuts
Oracle shares dropped 2.7% as its annual report disclosed 21,000 job cuts and a $23.7 billion negative free cash flow, intensifying worries about its AI-driven spending.